Last updated: February 29, 2024
Sponsor: University Medical Center Groningen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Depression
Treatment
GLI-LEEF
Clinical Study ID
NCT06286345
17644
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of depressive symptoms or depressive disorder in the past year as registeredin the general practice electronic health record and coded according to theInternational Classification of Primary Care (ICPC) as P03 and P76, respectively, orcurrently treated for depressive symptoms or depressive disorder in general practice.
- At least mild depressive symptom level according to the Quick Inventory DepressiveSymptomatology-Self-Report (QIDS-SR) (score ≥6)
- Body mass index ≥ 25 kg/m2 or increased waist circumference (>88 cm (women) of >102 cm (men)).
Exclusion
Exclusion Criteria:
- Current treatment in mental health care (GGZ in Dutch)
- Severe somatic / neurological disease at the discretion of the GP
- Currently participating in another lifestyle intervention
- Insufficient proficiency in Dutch
- Inability to read and write
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: GLI-LEEF
Phase:
Study Start date:
August 01, 2023
Estimated Completion Date:
July 01, 2025
Study Description
Connect with a study center
University Medical Center Groningen
Groningen, 9700 AD
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.